Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences, Unit Ii, Raichur, Karnataka Has Cleared Pmda Japan, GMP Inspection
01/09/2023 13:12
Sept 1 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA PHARMA LIFESCIENCES, UNIT II, RAICHUR, KARNATAKA
HAS
CLEARED PMDA JAPAN, GMP INSPECTION
Source text for Eikon: ID:nBSE9mTN1k
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026